Koers Edwards Lifesciences Corporation Borsa Italiana
Aandelen
4EW
US28176E1082
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
81,6 EUR | -1,19% | +1,33% | +17,28% |
26/04 | EDWARDS LIFESCIENCES CORPORATION : Evercore ISI herhaalt koopadvies | ZM |
26/04 | EDWARDS LIFESCIENCES CORPORATION : Stifel Nicolaus blijft neutraal | ZM |
Omzet 2024 * | 6,56 mld. 6,13 mld. | Omzet 2025 * | 7,19 mld. 6,73 mld. | Marktkapitalisatie | 52,02 mld. 48,66 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,61 mld. 1,51 mld. | Nettowinst (verlies) 2025 * | 1,84 mld. 1,72 mld. | EV/omzet 2024 * | 7,67 x |
Nettoliquiditeiten 2024 * | 1,7 mld. 1,59 mld. | Nettoliquiditeiten 2025 * | 2,89 mld. 2,7 mld. | EV/omzet 2025 * | 6,83 x |
K/w-verhouding 2024 * |
32,4
x | K/w-verhouding 2025 * |
28,5
x | Werknemers | 19.800 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,59% |
Recentste transcriptie over Edwards Lifesciences Corporation
1 dag | -1,19% | ||
1 week | +1,33% | ||
Lopende maand | -7,42% | ||
1 maand | -5,86% | ||
3 maanden | +21,25% | ||
6 maanden | +34,39% | ||
Lopend jaar | +17,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-01-15 | |
Chairman | 71 | 01-01-00 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 05-07-16 |
Director/Board Member | 67 | 13-11-14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-16 |
Datum | Koers | Variatie |
---|---|---|
26-04-24 | 81,03 | -0,70% |
25-04-24 | 81,6 | -1,19% |
24-04-24 | 82,58 | +1,14% |
23-04-24 | 81,65 | +1,08% |
22-04-24 | 80,78 | +0,31% |
slotkoers Borsa Italiana, 25 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,07% | 219 mld. | |
+6,59% | 183 mld. | |
+11,26% | 133 mld. | |
+26,57% | 108 mld. | |
+0,65% | 63,06 mld. | |
-0,62% | 48,2 mld. | |
-0,93% | 40,37 mld. | |
+11,54% | 39,35 mld. | |
+26,76% | 32,03 mld. |